Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) EBT Margin (2019 - 2023)

Benitec Biopharma (BNTC) has disclosed EBT Margin for 5 consecutive years, with 65114.29% as the latest value for Q2 2023.

  • Quarterly EBT Margin changed N/A to 65114.29% in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 307371.43% through Mar 2024, down 27898319.0% year-over-year, with the annual reading at 25485.33% for FY2023, 98396.0% down from the prior year.
  • EBT Margin hit 65114.29% in Q2 2023 for Benitec Biopharma, down from 8051.85% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 8220.0% in Q2 2020 to a low of 379500.0% in Q1 2021.
  • Historically, EBT Margin has averaged 80666.78% across 5 years, with a median of 8051.85% in 2023.
  • Biggest five-year swings in EBT Margin: plummeted -37201786bps in 2021 and later skyrocketed 37227083bps in 2022.
  • Year by year, EBT Margin stood at 2719.48% in 2019, then tumbled by -11891bps to 326100.0% in 2020, then skyrocketed by 94bps to 19384.0% in 2021, then tumbled by -107bps to 40135.71% in 2022, then crashed by -62bps to 65114.29% in 2023.
  • Business Quant data shows EBT Margin for BNTC at 65114.29% in Q2 2023, 8051.85% in Q1 2023, and 40135.71% in Q4 2022.